分组1 - Patterson Cos. reported quarterly earnings of $0.47 per share, missing the Zacks Consensus Estimate of $0.49 per share, and down from $0.50 per share a year ago, representing an earnings surprise of -4.08% [1] - The company posted revenues of $1.67 billion for the quarter ended October 2024, surpassing the Zacks Consensus Estimate by 2.13%, compared to year-ago revenues of $1.65 billion [2] - Patterson Cos. shares have lost about 23.1% since the beginning of the year, while the S&P 500 has gained 27.6% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.65 on $1.63 billion in revenues, and for the current fiscal year, it is $2.32 on $6.58 billion in revenues [7] - The Zacks Industry Rank for Medical - Dental Supplies is currently in the bottom 42% of over 250 Zacks industries, indicating potential underperformance compared to the top 50% of ranked industries [8]

Financial Performance - Second quarter reported net sales increased 1.3 percent year-over-year to $1.67 billion, with internal sales increasing 0.6 percent[2]. - GAAP earnings for the second quarter were $0.30 per diluted share, while adjusted earnings were $0.47 per diluted share, both negatively impacted by a cybersecurity attack[3]. - Adjusted net income for the second quarter was $41.8 million, down from $47.3 million in the prior year, primarily due to lower sales of dental equipment[7]. - Net income attributable to Patterson Companies, Inc. for the three months ended October 26, 2024, was $26,769, down 33.1% from $39,958 in the prior year[36]. - For the six months ended October 26, 2024, total net sales were $3,216,117, a decrease of 0.4% from $3,229,517 in the same period in 2023[44]. - Net income attributable to Patterson Companies, Inc. for the six months was $40,484,000, with diluted earnings per share of $0.46[51]. Shareholder Returns - The company returned $96.2 million to shareholders through cash dividends and share repurchases in the first six months of fiscal 2025[3]. - Dividends declared per common share remained stable at $0.26 for both the current and prior year periods[36]. Guidance and Strategic Initiatives - Fiscal 2025 GAAP earnings guidance revised to a range of $1.83 to $1.93 per diluted share, and adjusted earnings guidance to $2.25 to $2.35 per diluted share[3][15]. - The company is evaluating strategic alternatives to maximize shareholder value, which may include a sale, merger, or other transactions[18]. - The company plans to continue investing in higher margin products and services to support long-term growth[5]. Segment Performance - Dental segment reported net sales of $611.7 million, with internal sales decreasing 2.3 percent year-over-year, while Animal Health segment reported net sales of $1.05 billion, with internal sales increasing 1.9 percent[8][10]. - Animal Health segment total sales increased by 2.9% to $1,054,588 for the three months ended October 26, 2024[42]. - Value-added services and other in the Animal Health segment saw a significant increase of 19.1% to $25,706 for the three months ended October 26, 2024[42]. - Corporate segment value-added services and other reported a net income of $8,105 for the three months ended October 26, 2024, compared to $1,769 in the same period last year, indicating a notable improvement[46]. Cash Flow and Assets - Free cash flow improved by $41.5 million compared to the first six months of fiscal 2024, generating $38.4 million in cash[11]. - Cash and cash equivalents increased to $157,935 as of October 26, 2024, from $114,462 at the end of the previous period, marking a rise of 38.0%[38]. - Total current assets rose to $1,842,017 as of October 26, 2024, compared to $1,778,763 at the end of April 2024, an increase of 3.6%[38]. - Net cash used in operating activities for the six months ended October 26, 2024, was $(458,675), compared to $(485,276) for the same period last year, showing an improvement of 5.5%[40]. - Free cash flow for the six months ended October 26, 2024, was $12,159,000, compared to a negative free cash flow of $(29,291,000) for the same period in 2023[53]. Operating Metrics - Gross profit for the six months ended October 26, 2024, was $640,701, down from $658,081 in the prior year, reflecting a decrease of 2.1%[36]. - Operating income for the three months ended October 26, 2024, was $37,636, a decline of 34.1% compared to $56,903 for the same period last year[36]. - Operating income for the six months was $67,005,000, with operating expenses of $573,696,000[51]. - The company reported a decrease in operating expenses to $290,456 for the three months ended October 26, 2024, compared to $282,123 in the same period last year, an increase of 2.4%[36]. - The gross profit margin for the three months ended October 26, 2024, was 19.6%, compared to 20.0% for the same period in 2023[47].

Wall Street analysts expect Patterson Cos. (PDCO) to post quarterly earnings of $0.49 per share in its upcoming report, which indicates a year-over-year decline of 2%. Revenues are expected to be $1.64 billion, down 0.7% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company announces its earnings, it is ess ...

Patterson Companies, Inc. (PDCO) is set to release second-quarter fiscal 2025 results on Aug. 28, before the opening bell.The company missed on earnings in the last reported quarter. Its earnings missed the Zacks Consensus Estimate in three of the trailing four quarters and met in one, delivering a negative average surprise of 4.53%.Q2 EstimatesThe Zacks Consensus Estimate for the company’s revenues is pegged at $1.64 billion, down 0.7% year over year.The consensus mark for adjusted earnings per share is pi ...

Patterson Companies, Inc.'s (PDCO) subsidiary, Patterson Dental Supply, Inc., recently announced an agreement in principle between Patterson and PDS Health to extend their relationship through the end of 2027. The extension is expected to allow Patterson Companies to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS Health’s network of more than 1,000 supported practices nationwide.PDS Health, earlier known as Pacific Dental Services, is a renowned d ...

Patterson Companies (PDCO) recently announced that it has signed two separate acquisition agreements for its Animal Health business, Infusion Concepts in the United Kingdom and Mountain Vet Supply in the United States. These acquisition agreements are likely to further strengthen PDCO's Animal Health business. Terms of the transaction are not yet disclosed. Patterson Companies expects to close the transactions during the second quarter of fiscal 2025. Likely Trend of PDCO Stock Following the News Following ...

It has been about a month since the last earnings report for Patterson Cos. (PDCO) . Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Patterson Cos. due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Patterson Companies Q1 Earnings & Sal ...

Core Insights - Patterson Companies experienced a significant decline in share price following its fiscal 2025 Q1 update, with shares dropping 15.1% [1] - The company reported Q1 revenue of $1.54 billion, a decrease of 2.2% year over year, falling short of analyst expectations of $1.59 billion [1][2] - Q1 earnings per share were reported at $0.15 based on GAAP, with adjusted earnings per share at $0.24, which was below the consensus estimate of $0.32 [2] Revenue and Earnings Performance - The revenue for Q1 was $1.54 billion, down from the previous year, indicating a negative trend in sales performance [1] - The adjusted earnings per share of $0.24 was significantly lower than the expected $0.32, reflecting challenges in profitability [2] Factors Contributing to Disappointing Results - The CEO attributed the disappointing results to the impact of a cybersecurity attack on Change Healthcare, which created a backlog of unpaid claims affecting many healthcare companies [3] - Additionally, the companion animal business faced lower sales, with consumables and equipment sales declining by 3% and 3.8% year over year, respectively [4] - Timing of certain corporate expenses also played a role in the lower-than-expected results [4] Future Outlook and Investment Considerations - Despite the disappointing Q1 results, Patterson reaffirmed its full-year earnings guidance, suggesting confidence in future performance [5] - The stock is considered undervalued with a forward price-to-earnings ratio of 10.8 and a forward dividend yield exceeding 4%, making it an attractive option for value and income investors [5]

Patterson Companies, Inc. (PDCO) reported first-quarter fiscal 2025 adjusted earnings per share (EPS) of 24 cents, which missed the Zacks Consensus Estimate of 32 cents by 25%. The bottom line also declined 40% from the prior-year quarter's level. GAAP EPS in the quarter was 15 cents, down 53.1% from the bottom line recorded in the year-ago period. PDCO's Revenue Details Net sales in the quarter were $1.54 billion, which missed the Zacks Consensus Estimate by 3.8%. The top line declined 2.2% year over year. ...

For the quarter ended July 2024, Patterson Cos. (PDCO) reported revenue of $1.54 billion, down 2.2% over the same period last year. EPS came in at $0.24, compared to $0.40 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $1.6 billion, representing a surprise of -3.59%. The company delivered an EPS surprise of -25.00%, with the consensus EPS estimate being $0.32. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...